Literature DB >> 17986665

CD4+ T cells specific for glycoprotein B from cytomegalovirus exhibit extreme conservation of T-cell receptor usage between different individuals.

Laura Crompton1, Naeem Khan, Rajiv Khanna, Laxman Nayak, Paul A H Moss.   

Abstract

Antigen-specific CD8(+) cytotoxic T cells often demonstrate extreme conservation of T-cell receptor (TCR) usage between different individuals, but similar characteristics have not been documented for CD4(+) T cells. CD4(+) T cells predominantly have a helper immune role, but a cytotoxic CD4(+) T-cell subset has been characterized, and we have studied the cytotoxic CD4(+) T-cell response to a peptide from human cytomegalovirus glycoprotein B presented through HLA-DRB*0701. We show that this peptide elicits a cytotoxic CD4(+) T-cell response that averages 3.6% of the total CD4(+) T-cell repertoire of cytomegalovirus-seropositive donors. Moreover, CD4(+) cytotoxic T-cell clones isolated from different individuals exhibit extensive conservation of TCR usage, which indicates strong T-cell clonal selection for peptide recognition. Remarkably, this TCR sequence was recently reported in more than 50% of cases of CD4(+) T-cell large granular lymphocytosis. Immunodominance of cytotoxic CD4(+) T cells thus parallels that of CD8(+) subsets and suggests that cytotoxic effector function is critical to the development of T-cell clonal selection, possibly from immune competition secondary to lysis of antigen-presenting cells. In addition, these TCR sequences are highly homologous to those observed in HLA-DR7(+) patients with CD4(+) T-cell large granular lymphocytosis and implicate cytomegalovirus as a likely antigenic stimulus for this disorder.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17986665     DOI: 10.1182/blood-2007-04-079863

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

Review 1.  The immunology of human cytomegalovirus latency: could latent infection be cleared by novel immunotherapeutic strategies?

Authors:  Mark R Wills; Emma Poole; Betty Lau; Ben Krishna; John H Sinclair
Journal:  Cell Mol Immunol       Date:  2014-08-18       Impact factor: 11.530

Review 2.  Immunobiology of human cytomegalovirus: from bench to bedside.

Authors:  Tania Crough; Rajiv Khanna
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

Review 3.  CD4 CTL: living up to the challenge.

Authors:  Hilde Cheroutre; Mohammad Mushtaq Husain
Journal:  Semin Immunol       Date:  2013-11-15       Impact factor: 11.130

4.  Human Cytomegalovirus (HCMV)-Specific CD4+ T Cells Are Polyfunctional and Can Respond to HCMV-Infected Dendritic Cells In Vitro.

Authors:  Sarah E Jackson; George X Sedikides; Gavin M Mason; Georgina Okecha; Mark R Wills
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

5.  Characterization of CMV-specific CD4+ T-cell reconstitution following stem cell transplantation through the use of HLA Class II-peptide tetramers identifies patients at high risk of recurrent CMV reactivation.

Authors:  Mohammad Raeiszadeh; Annette Pachnio; Jusnara Begum; Charles Craddock; Paul Moss; Frederick E Chen
Journal:  Haematologica       Date:  2015-05-14       Impact factor: 9.941

6.  CMV exposure drives long-term CD57+ CD4 memory T-cell inflation following allogeneic stem cell transplant.

Authors:  Albert C Yeh; Antiopi Varelias; Anupama Reddy; Sierra M Barone; Stuart D Olver; Kate Chilson; Lynn E Onstad; Kathleen S Ensbey; Andrea S Henden; Luke Samson; Carla A Jaeger; Timothy Bi; Kimberly B Dahlman; Tae Kon Kim; Ping Zhang; Mariapia A Degli-Esposti; Evan W Newell; Madan H Jagasia; Jonathan M Irish; Stephanie J Lee; Geoffrey R Hill
Journal:  Blood       Date:  2021-12-30       Impact factor: 25.476

7.  HLA-DR and HLA-DP restricted epitopes from human cytomegalovirus glycoprotein B recognized by CD4+ T-cell clones from chronically infected individuals.

Authors:  Claire Ventura; Hélène Bisceglia; Yves Girerd-Chambaz; Nicolas Burdin; Pascal Chaux
Journal:  J Clin Immunol       Date:  2012-07-15       Impact factor: 8.317

8.  The Cellular Localization of Human Cytomegalovirus Glycoprotein Expression Greatly Influences the Frequency and Functional Phenotype of Specific CD4+ T Cell Responses.

Authors:  Annette Pachnio; Jianmin Zuo; Gordon B Ryan; Jusnara Begum; Paul A H Moss
Journal:  J Immunol       Date:  2015-09-11       Impact factor: 5.422

Review 9.  The shape of the lymphocyte receptor repertoire: lessons from the B cell receptor.

Authors:  Katherine J L Jackson; Marie J Kidd; Yan Wang; Andrew M Collins
Journal:  Front Immunol       Date:  2013-09-02       Impact factor: 7.561

10.  Cytomegalovirus (CMV) Epitope-Specific CD4+ T Cells Are Inflated in HIV+ CMV+ Subjects.

Authors:  Chike O Abana; Mark A Pilkinton; Silvana Gaudieri; Abha Chopra; Wyatt J McDonnell; Celestine Wanjalla; Louise Barnett; Rama Gangula; Cindy Hager; Dae K Jung; Brian G Engelhardt; Madan H Jagasia; Paul Klenerman; Elizabeth J Phillips; David M Koelle; Spyros A Kalams; Simon A Mallal
Journal:  J Immunol       Date:  2017-10-02       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.